Decrease seen in percentage of M. pneumoniae-related diagnoses during pandemic period, followed by postpandemic increase
Anakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
However, authors say anakinra may have a role as early treatment for patients with less severe COVID-19
COVID-19 Pneumonia More Fatal for Older Adults
COVID-19 tied to approximately doubled in-hospital mortality rates versus bacterial or other viral pneumonias
Inhaled Nitric Oxide May Ease Severe COVID-19 Pneumonia in Pregnant Women
High-dose inhaled nitric oxide linked to more days free from oxygen supplementation, shorter ICU and hospital length of stay
COVID-19 Pneumonia Hospitalization Tied to New-Onset Dementia
Rate significantly higher than seen with other pneumonias
Current Guidelines May Lead to Antibiotic Overuse for SARS-CoV-2 Pneumonia
Bacterial superinfection at time of intubation occurred in <25 percent of patients; reduced antibiotic use seen with bronchoalveolar lavage-based management versus current guidelines
ATS Guideline Addresses Testing for Viral Pathogens in CAP
Nucleic acid-based testing for noninfluenza pathogens suggested for hospitalized patients who have severe CAP or are immunocompromised
Mortality, Readmission Low With COVID-19 Discharge on Home Oxygen
All-cause mortality rate 1.3 percent; 30-day readmission rate 8.5 percent among 621 patients discharged on home oxygen
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
- Page 1 of 2
- 1
- 2